Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In partnership with the Wellcome Innovations Flagship Programme, MORU launched its Critical Care Asia Network project with its first investigators’ meeting on 19-20 Aug in Bangkok. The project will establish an Asian ICU network across 42 ICUs in nine countries and implement a setting-adapted electronic registry.

Using the registry as well as qualitative methods, this project will evaluate the quality of critical care within the network, which will then lead into locally-led quality improvement interventions aiming to improve ICU performance and patient outcomes.

Building on methodology developed by our partners in Sri Lanka, Pakistan and India, the electronic registry will provide epidemiological data and map processes of care, involving caregivers and patients and family members. This will be complemented by qualitative evaluations of care processes, with the aim to empower healthcare teams to identify targets for improvement. Quality improvement interventions and research will be driven by priorities set by the network collaborators. The project works in close collaboration with the Flagship project lead by the OUCRU team on developing new low-cost technologies for ICUs in low/middle income countries. The network will also provide a platform for clinical trials planned for the next phase of the project. Follow the project on Twitter, as well via Rashan’s Twitter handle.

Above photo, collaborators at the Bangkok meeting (front row, from left): Dr Khamsay Detleuxay, Dr Nguyen Thien Binh, Dr Lakshmi Rangananthan, Dr Sophie Yacoub, Dr Rebecca Inglis, Dr Gyan Kayastha, Dr Mavuto Mukaka, Dr Victoria Adewole, Dr Louise Thwaites; (middle row): Dr Nguyen Thanh Nguyen , Dr Dong Phu Khiem, Dilanthi Gamage, Dr Lam Minh Yen, Dr Kathleen Thomas, Dr Bui Thi Hanh Duyen,  Dr Duong Bich Thuy, Dr Madiha Hashmi, Prof Ramani Moonesinghe, Dr Rozina Sultana, Abi Beane, Dr Syed Muhammad Muneeb Ali; (back row): Dr Arshad Taqi, Dr Dinh Minh Duc, Dr Rashan Haniffa, Dr Will Schilling, Ishara Udayanga, Prof. Marcus Schultz, Dr Swagata Tripathy, Prof Arjen M. Dondorp, Dr Muhammad Hayat, Dr Diptesh Aryal. Absent: Dr Steve Harris, Dr Bharath Kumar, Dr Jorge Salluh, Dr Meghan Lever, Dr Chris Pell, Dr Tamilarasu Kadhiravan, Dr Chairat Permpikul, Dr Ratapum Champunot, Dr Gentle Shrestha, Dr Rajyabardhan Pattnaik, Prof Guy Thwaites and Prof Yoell Lubell.

­- With thanks to Abi Beane for text and Jan Ariyalikit for photos

Similar stories

Pint of Science Thailand is back

MORU Bangkok Public Engagement

Live and on-line from Bangkok! Be ready for Thursday 13th May, when Pint of Science Thailand will stream live from Bangkok. Join us via Facebook, YouTube or right here from the Pint of Science Thailand website as we journey from bacterial infections to viruses, discover how clinical trials work, and how scientific development is seen in the eyes of the law!

Innovative strategies for engaging communities with malaria research

MORU Bangkok Public Engagement

For World Malaria Day 2021, F1000 Research Blog spoke to Professor Phaik Yeong Cheah about her research focussed on drama and arts-based community engagement for malaria research, published with Wellcome Open Research.

New project’s child-appropriate primaquine doses could have significant impact on global burden of malaria

MORU Bangkok

On Sunday 25 April, World Malaria Day, the Developing Paediatric Primaquine (DPP) project will launch its website. DPP will produce children-appropriate primaquine doses that could both cut malaria deaths in vulnerable African children by blocking transmission of P. falciparum malaria and reduce P. vivax malaria more widely.

Researchers call for access to Ivermectin for young children

MORU Bangkok Publication Research

Millions of children weighing less than 15kg are currently denied access to Ivermectin treatment due to insufficient safety data being available to support a change to the current label indication. The WorldWide Antimalarial Resistance Network’s new meta-analysis provides evidence that supports removing this barrier and improving treatment equity.

New report highlights growing concern of vaccine falsification

MORU Bangkok

The Medicine Quality Research Group has published a new Medical Product Quality Report focussing on increasing issues around substandard and falsified (SF) COVID-19 vaccines. With the implementation of the key innovations of COVID-19 vaccines, there have been growing numbers of reports of SF vaccines in the public domain. Given the vital role they will play in ending the pandemic and protecting the global population but severe issues with equitable access, SF vaccines are highly likely to be a growing problem.

Evidence supports WHO recommendation for primaquine combined with ACTs to block Plasmodium falciparum transmission

MORU Bangkok Publication Research

Evidence from a new study, initiated by the Primaquine Roll Out Group and conducted at WWARN, supports the World Health Organization (WHO) recommendation for use of 0.25mg/kg dose of primaquine (PQ) combined with artemisinin-based combination therapies (ACT) to block Plasmodium falciparum transmission.